These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8140378)

  • 21. Controlling apoptosis: implications for carcinogenesis?
    Clarke AR
    Symp Soc Exp Biol; 2000; 52():265-75. PubMed ID: 12090014
    [No Abstract]   [Full Text] [Related]  

  • 22. The molecular perspective: p53 tumor suppressor.
    Goodsell DS
    Oncologist; 1999; 4(2):138-9. PubMed ID: 10337384
    [No Abstract]   [Full Text] [Related]  

  • 23. Human tumor suppressor p53 and DNA viruses.
    Collot-Teixeira S; Bass J; Denis F; Ranger-Rogez S
    Rev Med Virol; 2004; 14(5):301-19. PubMed ID: 15334538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P53 regulation and function in normal cells and tumors.
    Liu Y; Kulesz-Martin M
    Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of p53 anti-oncogene in normal and neoplastic cells].
    Vojtĕsek B
    Cas Lek Cesk; 1997 Dec; 136(23):11-3. PubMed ID: 9476369
    [No Abstract]   [Full Text] [Related]  

  • 27. The dual role of mutant p53 protein in chemosensitivity of human cancers.
    Mueller H; Eppenberger U
    Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 29. p53 in recombination and repair.
    Gatz SA; Wiesmüller L
    Cell Death Differ; 2006 Jun; 13(6):1003-16. PubMed ID: 16543940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair is activated in early stages of p53-induced apoptosis.
    Geske FJ; Nelson AC; Lieberman R; Strange R; Sun T; Gerschenson LE
    Cell Death Differ; 2000 Apr; 7(4):393-401. PubMed ID: 10773824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 and response to chemotherapy and radiotherapy.
    Ruley HE
    Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127
    [No Abstract]   [Full Text] [Related]  

  • 32. The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.
    Søe K; Hartmann H; Schlott B; Stevnsner T; Grosse F
    Oncogene; 2002 Sep; 21(43):6614-23. PubMed ID: 12242659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.
    Levine AJ
    Biol Chem Hoppe Seyler; 1993 Apr; 374(4):227-35. PubMed ID: 8329141
    [No Abstract]   [Full Text] [Related]  

  • 35. Death squads enlisted by the tumour suppressor p53.
    Michalak E; Villunger A; Erlacher M; Strasser A
    Biochem Biophys Res Commun; 2005 Jun; 331(3):786-98. PubMed ID: 15865934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dark side of a tumor suppressor: anti-apoptotic p53.
    Jänicke RU; Sohn D; Schulze-Osthoff K
    Cell Death Differ; 2008 Jun; 15(6):959-76. PubMed ID: 18356920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [P53 and its role in the ovarian surface epithelium. A review].
    Chuaire-Noack L; Sánchez-Corredor MC; Ramírez-Clavijo S
    Invest Clin; 2008 Dec; 49(4):561-93. PubMed ID: 19245174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells.
    Yang T; Namba H; Hara T; Takmura N; Nagayama Y; Fukata S; Ishikawa N; Kuma K; Ito K; Yamashita S
    Oncogene; 1997 Apr; 14(13):1511-9. PubMed ID: 9129141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the transcription factor p53 in keratinocyte carcinomas.
    Brash DE
    Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.